Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate

Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate

Prostate Cancer and Prostatic Diseases advance online publication, July 22 2014.
doi:10.1038/pcan.2014.27

Authors: W Kim, J O Jones, M Diamond, C Haqq, A Molina, E J Small & C J Ryan

Source: Prostate Cancer and Prostatic Diseases - July 22, 2014 Category: Urology & Nephrology Authors: W KimJ O JonesM DiamondC HaqqA MolinaE J SmallC J Ryan Source Type: research